Matthew Hotchko

Biotech professional

[Matthew Hotchko @MatthewHotchko]

@MatthewBerman @bot Would like to use it for clinical trials market research.

[Matthew Hotchko @MatthewHotchko]

@nicochristie Would like to try Shortcut for my market research business.

[Matthew Hotchko @MatthewHotchko]

@Teslarati I have the new Model Y and it is great. Very quiet and great suspension
The looks are good too, definitely an upgrade and a great refresh.

[Matthew Hotchko @MatthewHotchko]

@SawyerMerritt I was one of those new car sales in Spain, with delivery March 29th with a new Model Y! Finally bought one after being a fan for a long time and showing support for the company.

[Matthew Hotchko @MatthewHotchko]

@BishopBarron what are your thoughts on the world as a simulation we live in. Elon Musk spoke about it yest@1:15:00 https://t.co/KbfceeIElo

[Matthew Hotchko @MatthewHotchko]

Sangamo has IND for gene editing for hemophilia B. New era in a $1.3B market with many gene therapy competitors. https://t.co/WdefEt9ilz

[Matthew Hotchko @MatthewHotchko]

@AndyBiotech @BioRunUp @BuyersStrike Looks like time for them to go shopping, moving into the downstream space to capture more value/revenue

[Matthew Hotchko @MatthewHotchko]

@AlpineBV_Miller @BioRunUp @biotechtraderHB Worse coverage with sky high deductibles for me, esp for upcoming 2016. Can't afford it anymore

[Matthew Hotchko @MatthewHotchko]

@benstarnesmd looking forward to hearing updates from you

[Matthew Hotchko @MatthewHotchko]

The pharmaceutical sales boom for international drug makers in China was never meant to last, despite hope by some. http://t.co/5uhfK5ip1x

[Matthew Hotchko @MatthewHotchko]

It will be genetic sequencing that brings the big tech companies the fastest into the biotech world: http://t.co/60hwoEjoZm